Non-24-hour Sleep-wake Disorder
📧 Sign up to get email alerts when something new happens for Non-24-hour Sleep-wake Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: Breath Biomarkers for Sleep Loss and Circadian Timing
A terminated Brigham and Women's Hospital clinical trial investigated breath biomarkers for sleep loss and circadian timing in shift-work an…
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception [Phase 3]
Phase 3 safety trial update for tasimelteon in blind individuals with no light perception and non-24-hour sleep-wake disorder; status indica…
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™) [Phase 4]
Open-label Phase 4 study assessing the absolute bioavailability of tasimelteon (HETLIOZ) in adults with non-24-hour sleep-wake disorder; res…
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception [Phase 3]
Phase 3 clinical trial of tasimelteon for Non-24-Hour Sleep-Wake Disorder in blind individuals with no light perception has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-16Clinical Trial Update: Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder [Phase 3]
Phase 3 trial evaluating the efficacy and safety of tasimelteon versus placebo in totally blind individuals with Non-24-Hour Sleep-Wake Diso…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-10-10Clinical Trial Update: Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder [Phase 3]
A Phase 3 withdrawal study evaluating the maintenance effect of tasimelteon for Non-24-Hour Sleep-Wake Disorder; the study is completed with…
-
CLINICAL_TRIALS trial_result · 2009-09-09Clinical Trial Update: Efficacy and Safety of Circadin for Non-24 Hour Sleep-Wake Disorder in Totally Blind Subjects [Phase 2]
Phase 2 trial updates show Circadin (melatonin) demonstrating efficacy and safety for Non-24-hour sleep-wake disorder in totally blind subje…